CI Cigna PE ratio, current and historical analysis
The current price-to-earnings ratio for Cigna stock as of Feb 21, 2025 is 27.94. This is calculated based on the current EPS of $10.73 and the stock price of $299.81 per share. The PE ratio has increased by 7% from the past four quarters average of 26.1.
CI PE ratio history
The average historical PE ratio of Cigna for the last ten years is 16.42. The current P/E ratio of 27.94 is 70% higher than the historical average. In the past ten years, CI's PE ratio peaked in the Sep 2024 quarter at 32.29, when the stock price was $346.44 and the EPS was $10.73. The lowest point was in the Sep 2021 quarter, when it reached 8.39 with a price of $200.16 and an EPS of $23.87.
Cigna PE ratio by year
Maximum annual increase: 76.65% in 2013
Maximum annual decrease: -53.71% in 2009
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2023 | 17.04 | 11.37% | $299.45 | $17.57 |
| 2022 | 15.3 | 5.88% | $331.34 | $21.66 |
| 2021 | 14.45 | 60.91% | $229.63 | $15.89 |
| 2020 | 8.98 | -40.37% | $208.18 | $23.17 |
| 2019 | 15.06 | -15.25% | $204.49 | $13.58 |
| 2018 | 17.77 | -21.96% | $189.92 | $10.69 |
| 2017 | 22.77 | 24.77% | $203.09 | $8.92 |
| 2016 | 18.25 | 1.9% | $133.39 | $7.31 |
| 2015 | 17.91 | 38.73% | $146.33 | $8.17 |
| 2014 | 12.91 | -22.09% | $102.91 | $7.97 |
| 2013 | 16.57 | 76.65% | $87.48 | $5.28 |
| 2012 | 9.38 | 3.88% | $53.46 | $5.7 |
| 2011 | 9.03 | 15.47% | $42 | $4.65 |
| 2010 | 7.82 | 5.25% | $36.66 | $4.69 |
| 2009 | 7.43 | -53.71% | $35.27 | $4.75 |
Cigna PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2024 | 32.29 | 25.69% | $346.44 | $10.73 |
| Jun 2024 | 25.69 | -12.86% | $330.57 | $12.87 |
| Mar 2024 | 29.48 | 73% | $363.19 | $12.32 |
| Dec 2023 | 17.04 | 7.51% | $299.45 | $17.57 |
| Sep 2023 | 15.85 | 26.09% | $286.07 | $18.05 |
| Jun 2023 | 12.57 | 9.78% | $280.6 | $22.33 |
| Mar 2023 | 11.45 | -25.16% | $255.53 | $22.31 |
| Dec 2022 | 15.3 | 16.97% | $331.34 | $21.66 |
| Sep 2022 | 13.08 | -15.67% | $277.47 | $21.22 |
| Jun 2022 | 15.51 | 5.8% | $263.52 | $16.99 |
| Mar 2022 | 14.66 | 1.45% | $239.61 | $16.35 |
| Dec 2021 | 14.45 | 72.23% | $229.63 | $15.89 |
| Sep 2021 | 8.39 | -19.17% | $200.16 | $23.87 |
| Jun 2021 | 10.38 | 0.1% | $237.07 | $22.84 |
| Mar 2021 | 10.37 | 15.48% | $241.74 | $23.31 |
CI average PE ratio chart
CI's current P/E ratio is above the 3, 5 and 10-year averages.
CI PE vs peers
In comparison to its peer UNH, CI's PE ratio is lower, but it is higher than HUM's and CNC's. Cigna's PE ratio is trading above the peer group average of 20.52.
| Stock name | PE ratio | Market cap |
|---|---|---|
| CNC Centene Corp | 9.11 | $28.61B |
| RGA Reinsurance Group Of America Inc | 17.37 | $12.5B |
| HUM Humana Inc | 25.57 | $30.87B |
| CI Cigna Corp | 27.94 | $83.39B |
| UNH Unitedhealth Group Inc | 30.03 | $429.24B |
Frequently asked questions
What is Cigna's PE ratio?
The price to earnings ratio for CI stock as of Feb 21, 2025, stands at 27.94.
What is the 3-year average PE ratio for Cigna (CI)?
The average PE ratio for CI stock over the past 3 years is 18.45.
What is the 5-year average PE ratio for Cigna (CI)?
The average PE ratio for CI stock over the past 5 years is 15.47.
What is the highest PE ratio for CI?
The highest quarterly PE ratio in the last ten years has been 32.29 and it was in the Sep 2024 quarter.
How does the current PE ratio for CI compare to its historical average?
The current price to earnings ratio of CI is 70% higher than the 10-year historical average.
How is CI's PE ratio calculated (Cigna PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Feb 21, 2025), Cigna's stock price is $299.81. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $10.73. Therefore, Cigna's PE ratio for today is 27.94. PE RATIO(27.94) = STOCK PRICE($299.81) / TTM EPS($10.73)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.